NO20030110L - Polymer-modifiserte bioaktive syntetiske kjemokiner, fremgangsmåter for deres fremstilling og anvendelse - Google Patents
Polymer-modifiserte bioaktive syntetiske kjemokiner, fremgangsmåter for deres fremstilling og anvendelseInfo
- Publication number
- NO20030110L NO20030110L NO20030110A NO20030110A NO20030110L NO 20030110 L NO20030110 L NO 20030110L NO 20030110 A NO20030110 A NO 20030110A NO 20030110 A NO20030110 A NO 20030110A NO 20030110 L NO20030110 L NO 20030110L
- Authority
- NO
- Norway
- Prior art keywords
- polymer
- processes
- preparation
- modified bioactive
- bioactive synthetic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
- C07K14/7158—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for chemokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pulmonology (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Vascular Medicine (AREA)
- Dermatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Rheumatology (AREA)
- Communicable Diseases (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Virology (AREA)
- Oncology (AREA)
- Cardiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21768300P | 2000-07-12 | 2000-07-12 | |
PCT/US2001/021933 WO2002004015A1 (en) | 2000-07-12 | 2001-07-12 | Polymer-modified bioactive synthetic chemokines, and methods for their manufacture and use |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20030110D0 NO20030110D0 (no) | 2003-01-09 |
NO20030110L true NO20030110L (no) | 2003-03-12 |
Family
ID=22812056
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20030110A NO20030110L (no) | 2000-07-12 | 2003-01-09 | Polymer-modifiserte bioaktive syntetiske kjemokiner, fremgangsmåter for deres fremstilling og anvendelse |
NO20030111A NO20030111L (no) | 2000-07-12 | 2003-01-09 | Kjemokinreseptor-modulatorer, deres fremstilling og anvendelse |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20030111A NO20030111L (no) | 2000-07-12 | 2003-01-09 | Kjemokinreseptor-modulatorer, deres fremstilling og anvendelse |
Country Status (14)
Country | Link |
---|---|
US (1) | US20050089970A1 (ja) |
EP (2) | EP1299415A4 (ja) |
JP (3) | JP2004502783A (ja) |
KR (2) | KR20030032977A (ja) |
CN (2) | CN1460023A (ja) |
AU (2) | AU2002218769A1 (ja) |
BR (2) | BR0112429A (ja) |
CA (2) | CA2412150A1 (ja) |
IL (2) | IL153789A0 (ja) |
MX (2) | MXPA03000310A (ja) |
NO (2) | NO20030110L (ja) |
RU (1) | RU2003104024A (ja) |
WO (2) | WO2002004015A1 (ja) |
ZA (2) | ZA200300313B (ja) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7482425B2 (en) | 1999-08-26 | 2009-01-27 | Amylin Pharmaceuticals, Inc. | Compositions for lipid matrix-assisted chemical ligation |
AU2001273388B2 (en) | 2000-09-08 | 2005-01-13 | Gryphon Therapeutics, Inc. | "Pseudo"-native chemical ligation |
EP1515990B1 (en) * | 2002-06-12 | 2007-04-11 | Applied Research Systems ARS Holding N.V. | Antagonists of cxcr3-binding cxc chemokines |
WO2004017999A1 (en) * | 2002-08-16 | 2004-03-04 | University Of Bern | Non-glycosylated polyacrylamide conjugates and their use for cytoprotection |
US7166574B2 (en) | 2002-08-20 | 2007-01-23 | Biosurface Engineering Technologies, Inc. | Synthetic heparin-binding growth factor analogs |
US7598224B2 (en) | 2002-08-20 | 2009-10-06 | Biosurface Engineering Technologies, Inc. | Dual chain synthetic heparin-binding growth factor analogs |
EP1653996A2 (en) * | 2003-08-08 | 2006-05-10 | Novo Nordisk Health Care AG | Use of galactose oxidase for selective chemical conjugation of protractor molecules to proteins of therapeutic interest |
US7414028B1 (en) | 2004-02-04 | 2008-08-19 | Biosurface Engineering Technologies, Inc. | Growth factor analogs |
US7528105B1 (en) | 2004-02-10 | 2009-05-05 | Biosurface Engineering Technologies | Heterodimeric chain synthetic heparin-binding growth factor analogs |
US7671012B2 (en) | 2004-02-10 | 2010-03-02 | Biosurface Engineering Technologies, Inc. | Formulations and methods for delivery of growth factor analogs |
ATE482228T1 (de) | 2004-02-20 | 2010-10-15 | Biosurface Eng Tech Inc | Positiver modulator des knochenmorphogenetisches protein-2 (bmp-2) |
EP1732942A4 (en) * | 2004-03-30 | 2008-12-03 | Amylin Pharmaceuticals Inc | SYNTHETIC CHEMOKINES, MANUFACTURING METHODS AND APPLICATIONS |
US8293890B2 (en) | 2004-04-30 | 2012-10-23 | Advanced Cardiovascular Systems, Inc. | Hyaluronic acid based copolymers |
CN100467487C (zh) * | 2004-12-14 | 2009-03-11 | 北京大学 | 具有多种功能的多肽 |
WO2006069449A1 (en) * | 2004-12-29 | 2006-07-06 | The University Of British Columbia | Chemokine receptor-independent immunomodulatory and anti-proliferative activity |
BRPI0618528A2 (pt) * | 2005-11-11 | 2012-04-17 | Proteogen Bio S R L | método de conversão de proteìnas ativas solúveis em água em proteìnas ativas hidrofóbicas, uso das mesmas para a preparação de camadas monomoleculares de proteìnas ativas orientadas e dispositivos compreendendo as ditas proteìnas |
GB0607774D0 (en) * | 2006-04-20 | 2006-05-31 | Renovo Group Plc | Medicaments |
US10741034B2 (en) * | 2006-05-19 | 2020-08-11 | Apdn (B.V.I.) Inc. | Security system and method of marking an inventory item and/or person in the vicinity |
EP2046350A4 (en) | 2006-06-22 | 2011-09-14 | Biosurface Eng Tech Inc | COMPOSITIONS AND METHOD FOR THE RELEASE OF A BMP-2 AMPLIFIER / COACTIVATOR FOR REINFORCED OSTEOGENESIS |
EP2117572A4 (en) * | 2006-12-22 | 2010-03-31 | Univ California | NOVEL FUSION MOLECULE BASED ON A NEW TAA VARIANT |
TWI405779B (zh) * | 2007-08-01 | 2013-08-21 | 私立中原大學 | 兩性高分子及其形成方法與應用 |
US7960336B2 (en) | 2007-08-03 | 2011-06-14 | Pharmain Corporation | Composition for long-acting peptide analogs |
WO2011097567A1 (en) * | 2010-02-08 | 2011-08-11 | Arizona Board Of Regents, A Body Corporate Of The State Of Arizona, Acting For And On Behalf Of Arizona State University | Rantes multiplexed assay, rantes variants related to disease, and rantes variants related to enzymatice activity |
HUE047077T2 (hu) * | 2012-06-29 | 2020-04-28 | Bristol Myers Squibb Co | Eljárások glikoprotein aggregáció csökkentésére |
US10995371B2 (en) | 2016-10-13 | 2021-05-04 | Apdn (B.V.I.) Inc. | Composition and method of DNA marking elastomeric material |
US10920274B2 (en) | 2017-02-21 | 2021-02-16 | Apdn (B.V.I.) Inc. | Nucleic acid coated submicron particles for authentication |
CN110892990B (zh) * | 2019-10-11 | 2023-03-31 | 内蒙古伊利实业集团股份有限公司 | 益生菌益生元食用组合物及其应用 |
CN112129946A (zh) * | 2020-08-16 | 2020-12-25 | 陆修委 | 无糖链型惰性蛋白封闭剂的制备方法及应用 |
Family Cites Families (58)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4179337A (en) * | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
DE3815826A1 (de) * | 1988-05-09 | 1989-11-23 | Henkel Kgaa | Verfahren zur herstellung von vicinal diacyloxysubstituierten verbindungen |
US5470829A (en) * | 1988-11-17 | 1995-11-28 | Prisell; Per | Pharmaceutical preparation |
CA2006596C (en) * | 1988-12-22 | 2000-09-05 | Rika Ishikawa | Chemically-modified g-csf |
US5089261A (en) * | 1989-01-23 | 1992-02-18 | Cetus Corporation | Preparation of a polymer/interleukin-2 conjugate |
EP0460101A4 (en) * | 1989-02-24 | 1992-04-15 | Immunotherapeutics, Inc. | Immobilized cytokines |
US5122614A (en) * | 1989-04-19 | 1992-06-16 | Enzon, Inc. | Active carbonates of polyalkylene oxides for modification of polypeptides |
US5324844A (en) * | 1989-04-19 | 1994-06-28 | Enzon, Inc. | Active carbonates of polyalkylene oxides for modification of polypeptides |
IL90193A (en) * | 1989-05-04 | 1993-02-21 | Biomedical Polymers Int | Polurethane-based polymeric materials and biomedical articles and pharmaceutical compositions utilizing the same |
US5312808A (en) * | 1989-11-22 | 1994-05-17 | Enzon, Inc. | Fractionation of polyalkylene oxide-conjugated hemoglobin solutions |
US5650388A (en) * | 1989-11-22 | 1997-07-22 | Enzon, Inc. | Fractionated polyalkylene oxide-conjugated hemoglobin solutions |
US5275838A (en) * | 1990-02-28 | 1994-01-04 | Massachusetts Institute Of Technology | Immobilized polyethylene oxide star molecules for bioapplications |
US5171264A (en) * | 1990-02-28 | 1992-12-15 | Massachusetts Institute Of Technology | Immobilized polyethylene oxide star molecules for bioapplications |
US5219564A (en) * | 1990-07-06 | 1993-06-15 | Enzon, Inc. | Poly(alkylene oxide) amino acid copolymers and drug carriers and charged copolymers based thereon |
WO1992004942A1 (en) * | 1990-09-19 | 1992-04-02 | Atlantic Richfield Company | High-stability foams for long-term suppression of hydrocarbon vapors |
FR2672053B1 (fr) * | 1991-01-30 | 1993-04-23 | Atochem | Polyether bloc amides, leur procede de synthese. |
FR2673946B1 (fr) * | 1991-03-15 | 1993-05-28 | Atochem | Polyether bloc amides, leur procede de synthese. |
US5281698A (en) * | 1991-07-23 | 1994-01-25 | Cetus Oncology Corporation | Preparation of an activated polymer ester for protein conjugation |
EP0625996B1 (en) * | 1992-02-13 | 1997-04-23 | Carlsberg A/S | Polyethylene glycol or polypropylene glycol containing polymer |
US5614549A (en) * | 1992-08-21 | 1997-03-25 | Enzon, Inc. | High molecular weight polymer-based prodrugs |
US5298643A (en) * | 1992-12-22 | 1994-03-29 | Enzon, Inc. | Aryl imidate activated polyalkylene oxides |
US5349001A (en) * | 1993-01-19 | 1994-09-20 | Enzon, Inc. | Cyclic imide thione activated polyalkylene oxides |
US5321095A (en) * | 1993-02-02 | 1994-06-14 | Enzon, Inc. | Azlactone activated polyalkylene oxides |
US5589356A (en) * | 1993-06-21 | 1996-12-31 | Vanderbilt University | Litigation of sidechain unprotected peptides via a masked glycoaldehyde ester and O,N-acyl rearrangement |
US5880131A (en) * | 1993-10-20 | 1999-03-09 | Enzon, Inc. | High molecular weight polymer-based prodrugs |
US5965566A (en) * | 1993-10-20 | 1999-10-12 | Enzon, Inc. | High molecular weight polymer-based prodrugs |
US5840900A (en) * | 1993-10-20 | 1998-11-24 | Enzon, Inc. | High molecular weight polymer-based prodrugs |
US5605976A (en) * | 1995-05-15 | 1997-02-25 | Enzon, Inc. | Method of preparing polyalkylene oxide carboxylic acids |
US5643575A (en) * | 1993-10-27 | 1997-07-01 | Enzon, Inc. | Non-antigenic branched polymer conjugates |
US5919455A (en) * | 1993-10-27 | 1999-07-06 | Enzon, Inc. | Non-antigenic branched polymer conjugates |
US5446090A (en) * | 1993-11-12 | 1995-08-29 | Shearwater Polymers, Inc. | Isolatable, water soluble, and hydrolytically stable active sulfones of poly(ethylene glycol) and related polymers for modification of surfaces and molecules |
US5618528A (en) * | 1994-02-28 | 1997-04-08 | Sterling Winthrop Inc. | Biologically compatible linear block copolymers of polyalkylene oxide and peptide units |
US5686110A (en) * | 1994-06-02 | 1997-11-11 | Enzon, Inc. | Water soluble complex of an alkyl or olefinic end capped polyalkylene oxide and a water insoluble substance |
US5730990A (en) * | 1994-06-24 | 1998-03-24 | Enzon, Inc. | Non-antigenic amine derived polymers and polymer conjugates |
US5824784A (en) * | 1994-10-12 | 1998-10-20 | Amgen Inc. | N-terminally chemically modified protein compositions and methods |
US5932462A (en) * | 1995-01-10 | 1999-08-03 | Shearwater Polymers, Inc. | Multiarmed, monofunctional, polymer for coupling to molecules and surfaces |
US5756593A (en) * | 1995-05-15 | 1998-05-26 | Enzon, Inc. | Method of preparing polyalkyene oxide carboxylic acids |
US5646285A (en) * | 1995-06-07 | 1997-07-08 | Zymogenetics, Inc. | Combinatorial non-peptide libraries |
US5672662A (en) * | 1995-07-07 | 1997-09-30 | Shearwater Polymers, Inc. | Poly(ethylene glycol) and related polymers monosubstituted with propionic or butanoic acids and functional derivatives thereof for biotechnical applications |
US5919442A (en) * | 1995-08-11 | 1999-07-06 | Dendritech, Inc. | Hyper comb-branched polymer conjugates |
JP4193917B2 (ja) * | 1995-12-18 | 2008-12-10 | アンジオデバイス インターナショナル ゲーエムベーハー | 架橋ポリマー組成物およびその使用方法 |
GB9712818D0 (en) * | 1996-07-08 | 1997-08-20 | Cambridge Antibody Tech | Labelling and selection of specific binding molecules |
JP4410852B2 (ja) * | 1996-08-02 | 2010-02-03 | オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド | 単一の共有結合n末端水溶性ポリマーを有するポリペプチド |
US6140064A (en) * | 1996-09-10 | 2000-10-31 | Theodor-Kocher Institute | Method of detecting or identifying ligands, inhibitors or promoters of CXC chemokine receptor 3 |
US6214966B1 (en) * | 1996-09-26 | 2001-04-10 | Shearwater Corporation | Soluble, degradable poly(ethylene glycol) derivatives for controllable release of bound molecules into solution |
US6214540B1 (en) * | 1997-03-26 | 2001-04-10 | University Of Maryland Biotechnology Institute | Chemokines that inhibit immunodeficiency virus infection and methods based thereon |
US5990237A (en) * | 1997-05-21 | 1999-11-23 | Shearwater Polymers, Inc. | Poly(ethylene glycol) aldehyde hydrates and related polymers and applications in modifying amines |
US6168784B1 (en) * | 1997-09-03 | 2001-01-02 | Gryphon Sciences | N-terminal modifications of RANTES and methods of use |
WO1999011655A1 (en) * | 1997-09-04 | 1999-03-11 | Gryphon Sciences | Modular protein libraries and methods of preparation |
US6011042A (en) * | 1997-10-10 | 2000-01-04 | Enzon, Inc. | Acyl polymeric derivatives of aromatic hydroxyl-containing compounds |
MXPA00003885A (es) * | 1997-10-22 | 2004-04-23 | Inst Genetics Llc | Quimiocinas con modificiaciones de la terminacion amino. |
US6111107A (en) * | 1997-11-20 | 2000-08-29 | Enzon, Inc. | High yield method for stereoselective acylation of tertiary alcohols |
US6180095B1 (en) * | 1997-12-17 | 2001-01-30 | Enzon, Inc. | Polymeric prodrugs of amino- and hydroxyl-containing bioactive agents |
US5985263A (en) * | 1997-12-19 | 1999-11-16 | Enzon, Inc. | Substantially pure histidine-linked protein polymer conjugates |
US5965119A (en) * | 1997-12-30 | 1999-10-12 | Enzon, Inc. | Trialkyl-lock-facilitated polymeric prodrugs of amino-containing bioactive agents |
US6090388A (en) * | 1998-06-20 | 2000-07-18 | United Biomedical Inc. | Peptide composition for prevention and treatment of HIV infection and immune disorders |
CA2335105C (en) * | 1998-07-22 | 2010-05-11 | Osprey Pharmaceuticals Limited | Methods and compositions for treating secondary tissue damage and other inflammatory conditions and disorders |
AU2001273388B2 (en) * | 2000-09-08 | 2005-01-13 | Gryphon Therapeutics, Inc. | "Pseudo"-native chemical ligation |
-
2001
- 2001-07-12 KR KR1020027018043A patent/KR20030032977A/ko not_active Application Discontinuation
- 2001-07-12 CA CA002412150A patent/CA2412150A1/en not_active Abandoned
- 2001-07-12 IL IL15378901A patent/IL153789A0/xx unknown
- 2001-07-12 AU AU2002218769A patent/AU2002218769A1/en not_active Abandoned
- 2001-07-12 WO PCT/US2001/021933 patent/WO2002004015A1/en not_active Application Discontinuation
- 2001-07-12 CA CA002412162A patent/CA2412162A1/en not_active Abandoned
- 2001-07-12 US US10/332,039 patent/US20050089970A1/en not_active Abandoned
- 2001-07-12 JP JP2002509362A patent/JP2004502783A/ja active Pending
- 2001-07-12 JP JP2002508469A patent/JP2004517040A/ja active Pending
- 2001-07-12 AU AU2001273387A patent/AU2001273387A1/en not_active Abandoned
- 2001-07-12 BR BR0112429-3A patent/BR0112429A/pt not_active IP Right Cessation
- 2001-07-12 RU RU2003104024/15A patent/RU2003104024A/ru not_active Application Discontinuation
- 2001-07-12 MX MXPA03000310A patent/MXPA03000310A/es unknown
- 2001-07-12 EP EP01984163A patent/EP1299415A4/en not_active Withdrawn
- 2001-07-12 EP EP01952656A patent/EP1307216A4/en not_active Withdrawn
- 2001-07-12 IL IL15378501A patent/IL153785A0/xx unknown
- 2001-07-12 CN CN01815247A patent/CN1460023A/zh active Pending
- 2001-07-12 BR BR0112428-5A patent/BR0112428A/pt not_active IP Right Cessation
- 2001-07-12 KR KR10-2003-7000178A patent/KR20030036591A/ko not_active Application Discontinuation
- 2001-07-12 WO PCT/US2001/021934 patent/WO2002004499A1/en not_active Application Discontinuation
- 2001-07-12 MX MXPA03000311A patent/MXPA03000311A/es unknown
- 2001-07-12 CN CN01812629A patent/CN1441808A/zh active Pending
-
2003
- 2003-01-09 NO NO20030110A patent/NO20030110L/no not_active Application Discontinuation
- 2003-01-09 NO NO20030111A patent/NO20030111L/no not_active Application Discontinuation
- 2003-01-13 ZA ZA200300313A patent/ZA200300313B/en unknown
- 2003-01-13 ZA ZA200300312A patent/ZA200300312B/en unknown
-
2007
- 2007-05-09 JP JP2007125054A patent/JP2007302667A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2007302667A (ja) | 2007-11-22 |
NO20030111L (no) | 2003-03-12 |
WO2002004015A9 (en) | 2003-08-07 |
JP2004517040A (ja) | 2004-06-10 |
CN1460023A (zh) | 2003-12-03 |
ZA200300312B (en) | 2004-02-04 |
BR0112428A (pt) | 2003-11-25 |
EP1299415A1 (en) | 2003-04-09 |
ZA200300313B (en) | 2004-02-04 |
MXPA03000311A (es) | 2004-12-13 |
KR20030036591A (ko) | 2003-05-09 |
AU2001273387A1 (en) | 2002-01-21 |
KR20030032977A (ko) | 2003-04-26 |
IL153789A0 (en) | 2003-07-31 |
WO2002004015A1 (en) | 2002-01-17 |
CA2412162A1 (en) | 2002-01-17 |
EP1307216A4 (en) | 2005-01-12 |
BR0112429A (pt) | 2003-12-30 |
NO20030111D0 (no) | 2003-01-09 |
AU2002218769A1 (en) | 2002-01-21 |
US20050089970A1 (en) | 2005-04-28 |
MXPA03000310A (es) | 2004-12-13 |
CN1441808A (zh) | 2003-09-10 |
RU2003104024A (ru) | 2004-06-27 |
IL153785A0 (en) | 2003-07-31 |
CA2412150A1 (en) | 2002-01-17 |
EP1307216A1 (en) | 2003-05-07 |
JP2004502783A (ja) | 2004-01-29 |
WO2002004499A1 (en) | 2002-01-17 |
EP1299415A4 (en) | 2005-01-19 |
NO20030110D0 (no) | 2003-01-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20030110D0 (no) | Polymer-modifiserte bioaktive syntetiske kjemokiner, fremgangsmåter for deres fremstilling og anvendelse | |
BR0103754B1 (pt) | artigo descartÁvel. | |
BR0105361B1 (pt) | artigo absorvente. | |
BR0100865B8 (pt) | artigo absorvente. | |
DE60032869D1 (de) | Wasserdispergierbarer absorbierender Artikel | |
BR0103836B1 (pt) | artigo absorvente. | |
DE60140246D1 (de) | Wärmende Zusammensetzung | |
DK1455785T3 (da) | Substituerede 2-thio-3,5-dicyano-4-phenyl-6-aminopyridiner og deres anvendelse | |
BR0214972B1 (pt) | artigo absorvente. | |
NO20015156L (no) | 5-pyridyl-1,3-azolforbindelser, deres fremstilling og anvendelse | |
BR0100151B1 (pt) | artigo absorvente. | |
NO20021449L (no) | Substituerte 2-tio-3,5-dicyano-4-aryl-6-aminopyridiner og deres anvendelse | |
NO20024742L (no) | Heterocykliske forbindelser, deres fremstilling og anvendelse | |
DE60115683D1 (de) | Biostabile kleine zuleitung | |
NO20014603L (no) | Tienopyrimidinforbindelser, deres fremstilling og anvendelse | |
BR0100961B1 (pt) | artigo absorvente. | |
NO20030800L (no) | Aminoalkylbenzoyl-benzofuran- eller benzotiofenderivater, fremgangsmåte forderes fremstilling og preparater inneholdende de samme | |
NO20031838D0 (no) | Benzokazinonderivater, deres fremstilling og anvendelse | |
DE60043769D1 (de) | Wasserdispergierbarer absorbierender Artikel | |
BR0102028B1 (pt) | artigo absorvente. | |
DE60102936D1 (de) | Antibakterielle mutiline | |
BR0100962B1 (pt) | artigo absorvente. | |
ID29706A (id) | Artikel kesehatan sekali pakai | |
BR0114005B1 (pt) | composição para tratamento de tecido | |
NO20025209L (no) | Cyklipostiner, deres fremstilling og anvendelse |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |